Leaflet PROPAFENONA ARENA 150mg film-coated tablets

Indicated for: cardiac arrhythmias

Route of administration: oral

Substance: propafenone (antiarrhythmic)

ATC: C01BC03 (Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic)

Precautions:
Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Propafenone is a medication used to treat cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia. It belongs to the class Ic antiarrhythmics and works by slowing the conduction of electrical impulses in the heart, restoring normal heart rhythm.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to monitor cardiac function during treatment to prevent complications.

Side effects may include dizziness, nausea, constipation, or fatigue. In rare cases, severe adverse effects such as worsening arrhythmias or heart failure may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as heart or liver diseases, to ensure the safe use of propafenone.

General data about PROPAFENONA ARENA 150mg

  • Substance: propafenone
  • Date of latest medicines list: 01-03-2017
  • Product code: W62994003
  • Concentration: 150mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 100
  • Product type: Generic medicine
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: ARENA GROUP S.A. - ROMANIA
  • Holder: ARENA GROUP S.A. - ROMANIA
  • Number: 9245/2016/03
  • Shelf life: 3 years

Concentrations available for propafenone

  • 150mg
  • 300mg
  • 35mg/10ml
  • 70mg/20ml